AAV-GBA1 gene therapy (Genzyme)

N/A

Report date: 2023/10/26 16:19:29

Base Information

Drug NameAAV-GBA1 gene therapy (Genzyme)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsGaucher Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBeth Israel Deaconess Medical CenterGenzyme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBeth Israel Deaconess Medical CenterGenzyme Corp
Active IndicationsN/A
Inactive IndicationsGaucher Disease

Other Information

ATC CodeN/A
Related LinksN/A